MNKD logo

MannKind (MNKD)

Profile

Full Name

MannKind Corporation

Ticker Symbol

MNKD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 28, 2004

Indexes

Not included

Website

http://www.mannkindcorp.com

Employees

403

Key Details

Price

$4.86

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$285.50M(+43.50% YoY)

Annual EPS

$0.10(+350.00% YoY)

PE Ratio

48.60

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.86
MNKD price is $4.86

Price All-time High

$118.55
MNKD price is currently -95.90% below its historical high of $118.55

Price Most Recent Change

-2.99%
MNKD price was down -2.99% on Apr 3, 2025

Price YTD Change

-26.14%
MNKD price is down -26.14% since January 1st

Price 1-year Change

+9.71%
MNKD price is up +9.71% year-on-year

Price 3-year Change

+25.26%
MNKD price is up +25.26% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$1.48B
MNKD market capitalization is $1.48 billion

Market Cap 3-year Change

+50.65%
MNKD market capitalization is up +50.65% over the past 3 years

Market Cap All-time High

$4.32B
MNKD market capitalization is currently -65.84% below its historical high of $4.32 billion

Market Cap Sector Rank

80.07%
MNKD market capitalization is higher than 80.07% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+12.11%
MNKD shares outstanding is up +12.11% year-on-year

Shares Outstanding 3-Year Change

+20.28%
MNKD shares outstanding is up +20.28% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.77
MNKD beta is 0.77

200-day SMA

$5.97
MNKD price is currently -18.58% below its 200-day simple moving average

50-day SMA

$5.41
MNKD price is currently -10.17% below its 50-day simple moving average

RSI

33.69
MNKD 14-day relative strength index is 33.69

Volume

0.97
MNKD 30-day relative volume is 0.97

ATR

$0.16
MNKD average true range is $0.16

10-day Historical Volatility

23.32%
MNKD 10-day historical volatility is 23.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$285.50M
MNKD annual revenue is $285.50 million

Revenue Analysts Estimate

$316.49M
MNKD annual revenue is currently -9.79% lower than the consensus analysts' forecast

Revenue 1-year Change

+43.5%
MNKD annual revenue is up +43.5% year-on-year

Revenue Sector Rank

69.29%
MNKD annual revenue is higher than 69.29% of companies in Healthcare sector

EPS

EPS

$0.10
MNKD annual earnings per share is $0.10

EPS Analysts Estimate

$0.17
MNKD annual earnings per share is currently -39.39% lower than the consensus analysts' forecast

EPS 1-year Change

+350%
MNKD annual earnings per share is up +350% year-on-year

EPS Sector Rank

83.32%
MNKD annual earnings per share is higher than 83.32% of companies in Healthcare sector

Profit

Gross Profit

$208.90M
MNKD annual gross profit is $208.90 million

Gross Margin

73.17%
MNKD annual gross profit margin is 73.17%

Operating Profit

$68.68M
MNKD annual operating income is $68.68 million

Operating Margin

24.06%
MNKD annual operating profit margin is 24.06%

Net Income

$27.59M
MNKD annual net profit is $27.59 million

Net Margin

9.66%
MNKD annual net profit margin is 9.66%

Expenses

Total Expenses

$216.82M
MNKD annual total expenses is $216.82 million

Operating Expenses

$140.22M
MNKD annual total operating expenses is $140.22 million

Cost Of Goods Sold

$76.60M
MNKD annual cost of goods sold is $76.60 million

Selling, General & Administrative Expenses

$94.33M
MNKD annual SGA is $94.33 million

Depreciation And Amortization

$9.04M
MNKD annual depreciation & amortization is $9.04 million

Interest Expense

$37.98M
MNKD annual interest expense is $37.98 million

Income Tax

$2.93M
MNKD annual income tax is $2.93 million

EBIT & EBITDA

EBIT

$68.50M
MNKD annual earnings before interest & taxes is $68.50 million

EBITDA

$77.54M
MNKD annual EBITDA is $77.54 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$393.84M
MNKD annual total assets is $393.84 million

Non Current Assets

$125.54M
MNKD annual long term assets is $125.54 million

Current Assets

$268.31M
MNKD annual total current assets is $268.31 million

Cash And Cash Equivalents

$46.34M
MNKD annual cash & cash equivalents is $46.34 million

Accounts Receivable

$11.80M
MNKD annual accounts receivable is $11.80 million

Inventory

$27.89M
MNKD annual inventory is $27.89 million

Liabilities

Total Liabilities

$472.66M
MNKD annual total liabilities is $472.66 million

Long Term Liabilities

$390.82M
MNKD annual total long term liabilities is $390.82 million

Current Liabilities

$81.84M
MNKD annual total current liabilities is $81.84 million

Accounts Payable

$6.79M
MNKD annual accounts payable is $6.79 million

Debt

Total Debt

$47.70M
MNKD annual total debt is $47.70 million

Total Debt 1-year Change

-82.5%
MNKD annual total debt is down -82.5% year-on-year

Long Term Debt

$47.70M
MNKD annual long term debt is $47.70 million

Short Term Debt

-
MNKD annual short term debt value is unknown

Equity & Capital

Shareholders Equity

-$78.82M
MNKD annual stockholders equity is -$78.82 million

Book Value

-$78.82M
MNKD annual book value is -$78.82 million

Retained Earnings

-$3.20B
MNKD annual retained earnings is -$3.20 billion

Working Capital

$186.47M
MNKD annual working capital is $186.47 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$42.51M
MNKD annual cash flow from operations is $42.51 million

Cash From Operations 1-year Change

+24.69%
MNKD annual cash flow from operations is up +24.69% year-on-year

Cash From Investing

-$96.65M
MNKD annual cash flow from investing activities is -$96.65 million

Cash From Investing 1-year Change

-4761.62%
MNKD annual cash flow from investing activities is down -4761.62% year-on-year

Cash From Financing

-$137.27M
MNKD annual cash flow from financing activities is -$137.27 million

Cash From Financing 1-year Change

-200.48%
MNKD annual cash flow from financing activities is down -200.48% year-on-year

CAPEX

CAPEX

$9.69M
MNKD annual capital expenditures is $9.69 million

CAPEX 1-year Change

-77.16%
MNKD annual capital expenditures is down -77.16% year-on-year

Free Cash Flow

Free Cash Flow

$32.82M
MNKD annual free cash flow is $32.82 million

Free Cash Flow 1-year Change

+493.17%
MNKD annual free cash flow is up +493.17% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

73.17%
MNKD annual gross profit margin is 73.17%

Operating Margin

24.06%
MNKD annual operating profit margin is 24.06%

Net Margin

9.66%
MNKD annual net profit margin is 9.66%

ROA & ROE

ROA

6.35%
MNKD annual return on assets is 6.35%

ROE

-35.00%
MNKD annual return on equity is -35.00%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

48.60
MNKD price to earnings ratio is 48.60

PE Ratio Sector Rank

78.64%
MNKD price to earnings ratio is higher than 78.64% of companies in Healthcare sector

PB Ratio

PB Ratio

-18.72
MNKD price to book ratio is -18.72

PB Ratio Sector Rank

1.97%
MNKD price to book ratio is higher than 1.97% of companies in Healthcare sector

PS Ratio

PS Ratio

5.17
MNKD price to sales ratio is 5.17

PS Ratio Sector Rank

66.58%
MNKD price to sales ratio is higher than 66.58% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.48B
MNKD enterprise value is $1.48 billion

Enterprise Value Sector Rank

78.66%
MNKD enterprise value is higher than 78.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

19.05
MNKD EV/EBITDA is 19.05

EV/EBITDA Sector Rank

90.58%
MNKD EV/EBITDA is higher than 90.58% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

3.28
MNKD annual current ratio is 3.28

Quick Ratio

2.94
MNKD annual quick ratio is 2.94

Leverage

Debt To Equity

-0.46
MNKD annual debt to equity ratio is -0.46

Interest Coverage Ratio

1.80
MNKD annual interest coverage ratio is 1.80

Risk & Stability

Piotroski F-Score

7
MNKD piotroski f-score is 7

Altman Z-Score

-7.64
MNKD altman z-score is -7.64

Analyst ratings

Recent major analysts updates

Dec 20, 24 Wells Fargo
Overweight
Dec 19, 24 RBC Capital
Outperform
Aug 28, 24 Oppenheimer
Outperform
Jun 13, 24 Rodman & Renshaw
Buy
May 9, 24 Cantor Fitzgerald
Overweight
Mar 15, 24 Cantor Fitzgerald
Overweight
Feb 28, 24 Cantor Fitzgerald
Overweight
Jan 4, 24 HC Wainwright & Co.
Buy
Oct 10, 23 Wedbush
Outperform
Aug 14, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MESO logo
Mesoblast Limited (MESO)
ATEC logo
Alphatec Holdings (ATEC)
TVTX logo
Travere Therapeutics (TVTX)
ANIP logo
ANI Pharmaceuticals (ANIP)
UFPT logo
UFP Technologies (UFPT)
PHR logo
Phreesia (PHR)
IMCR logo
Immunocore Holdings (IMCR)
VERA logo
Vera Therapeutics (VERA)
CGON logo
CG Oncology (CGON)
  • What is the ticker symbol for MannKind?
  • Does MannKind pay dividends?
  • What sector is MannKind in?
  • What industry is MannKind in?
  • What country is MannKind based in?
  • When did MannKind go public?
  • Is MannKind in the S&P 500?
  • Is MannKind in the NASDAQ 100?
  • Is MannKind in the Dow Jones?
  • When was MannKind's last earnings report?
  • When does MannKind report earnings?
  • Should I buy MannKind stock now?

What is the ticker symbol for MannKind?

The ticker symbol for MannKind is NASDAQ:MNKD

Does MannKind pay dividends?

No, MannKind does not pay dividends

What sector is MannKind in?

MannKind is in the Healthcare sector

What industry is MannKind in?

MannKind is in the Biotechnology industry

What country is MannKind based in?

MannKind is headquartered in United States

When did MannKind go public?

MannKind's initial public offering (IPO) was on July 28, 2004

Is MannKind in the S&P 500?

No, MannKind is not included in the S&P 500 index

Is MannKind in the NASDAQ 100?

No, MannKind is not included in the NASDAQ 100 index

Is MannKind in the Dow Jones?

No, MannKind is not included in the Dow Jones index

When was MannKind's last earnings report?

MannKind's most recent earnings report was on Feb 26, 2025

When does MannKind report earnings?

The next expected earnings date for MannKind is May 8, 2025

Should I buy MannKind stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page